Evan Seigerman, BMO Capital Markets, joins ‘Fast Money’ to talk to Nono Nordisk sinking on guidance cut.
Source link
Trending
- Why companies clear the deck for new CEOs
- Comcast (CMCSA) earnings Q2 2025
- Microsoft is surging following its earnings beat. Here’s what analysts are saying
- Moderna to slash 10% of workforce amid Covid vaccine sales
- CoreWeave is a buy after Microsoft’s strong earnings report, Citi says
- MLB taps NASCAR to help grow baseball with Speedway Classic
- UK CMA finds Microsoft and Amazon are hurting cloud competition
- Jim Cramer says he’s confident on Starbucks in the long-term
Novo Nordisk needs something new, outside of weigh-loss drugs, says BMO's Seigerman
